PACIRA BIOSCIENCES INC. - COMMON STOCK
26.95
01-May-24 15:59:56
15 minutes delayed
Stocks
+0.70
+2.67%
Today's range
26.27 - 27.12
ISIN
N/A
Source
NASDAQ
-
06 Sep 2023 08:00:00 By Nasdaq GlobeNewswire
-
NetDania - New 12 months Low: PACIRA BIOSCIENCES INC. - COMMON STOCK
02 Aug 2023 09:45:11 By NetDania Notify
-
Pacira BioSciences Reports Second Quarter 2023 Financial Results
02 Aug 2023 08:00:01 By Nasdaq GlobeNewswire
-
Pacira to Report Second Quarter 2023 Financial Results on Wednesday August 2, 2023
26 Jul 2023 08:00:00 By Nasdaq GlobeNewswire
-
Pacira BioSciences to Participate in Fireside Chat at the 2023 Jefferies Healthcare Conference
31 May 2023 08:00:01 By Nasdaq GlobeNewswire
-
09 May 2023 08:00:02 By Nasdaq GlobeNewswire
-
Pacira BioSciences Reports First Quarter 2023 Financial Results
03 May 2023 08:00:01 By Nasdaq GlobeNewswire
-
Pacira to Report First Quarter 2023 Financial Results on Wednesday May 3, 2023
26 Apr 2023 08:00:01 By Nasdaq GlobeNewswire
-
20 Apr 2023 08:00:01 By Nasdaq GlobeNewswire
-
Pacira BioSciences, Inc. Appoints Christopher Young as Chief Manufacturing Officer
19 Apr 2023 08:00:01 By Nasdaq GlobeNewswire
-
03 Apr 2023 08:00:01 By Nasdaq GlobeNewswire
-
29 Mar 2023 08:00:00 By Nasdaq GlobeNewswire
-
Third Circuit Court Upholds Decision to Dismiss Pacira BioSciences, Inc. Lawsuit
27 Mar 2023 08:00:00 By Nasdaq GlobeNewswire
-
Pacira BioSciences Announces Yvonne Greenstreet to Retire from Board of Directors
22 Mar 2023 08:00:01 By Nasdaq GlobeNewswire
-
Pacira BioSciences to Participate in Fireside Chat at the 2023 Barclays Global Healthcare Conference
08 Mar 2023 08:00:01 By Nasdaq GlobeNewswire
-
Pacira BioSciences Reports Full-Year and Fourth Quarter 2022 Financial Results
28 Feb 2023 08:00:03 By Nasdaq GlobeNewswire
-
LPGA, Pacira BioSciences Partner to Raise Awareness of Non-Opioid Pain Management Solutions
23 Feb 2023 08:00:02 By Nasdaq GlobeNewswire
-
Pacira BioSciences Reports Preliminary Unaudited Total Revenue for 2022 of $666.8 Million
05 Jan 2023 16:30:00 By Nasdaq GlobeNewswire
-
Pacira BioSciences to Present at the 41st Annual J.P. Morgan Healthcare Conference
04 Jan 2023 08:00:01 By Nasdaq GlobeNewswire
-
Pacira BioSciences Reports Preliminary Net Product Sales of $57.5 Million for November 2022
13 Dec 2022 08:00:02 By Nasdaq GlobeNewswire